Is accurate preoperative assessment of pancreatic cystic lesions possible?
Authors:
P. Záruba 1
; T. Dvořáková 2; F. Závada 3; F. Bělina 1; M. Ryska 1
Authors place of work:
Chirurgická klinika 2. LF UK a ÚVN, Praha, přednosta: prof. MUDr. M. Ryska, CSc.
1; Oddělení gastroenterologie, hepatologie a metabolismu, Interní klinika 1. LF UK a ÚVN, Praha
přednosta: Prof. MUDr. M. Zavoral Ph. D.
2; Interní oddělení, Oblastní nemocnice Příbram, a. s., primář: MUDr., Ing. F. Závada PhD.
3
Published in the journal:
Rozhl. Chir., 2013, roč. 92, č. 12, s. 708-714.
Category:
Original articles
Summary
Introduction:
Cystic lesions of the pancreas (CLP) are of different origin and behaviour. Mucinous lesions with the risk of invasive cancer represent an important subgroup. The key point in differential diagnosis of CLP is to distinguish malignant and benign lesions and also correct indication for surgery in order to minimize the impact of serious complications after resection. Different and unsatisfying predictive values of each of the examinations make proper diagnosis challenging. We focused on overall diagnostic accuracy of preoperative imaging and analytic studies. We studied the accuracy of distinguishing between non-neoplastic vs. neoplastic and bening vs. malignant lesions.
Material and methods:
We retrospectively analyzed all of the patients (N=72) with CLP (median of age 58 years, range 22–79) recommended for surgery. CT, EUS, ERCP, MRCP findings, cytology and aspirate analysis were used to establish preoperative diagnosis. Finally, preoperative diagnoses were compared with postoperative pathological findings to establish overall accuracy of preoperative assessment.
Results:
During 5 years, 72 patients underwent resection for CLP. We performed 66 (92%) resection and 6 (8%) palliative procedures with 32% morbidity and 7% of one hospital stay mortality. All the patients were examined by CT and EUS. FNA was performed in 44 (61%) patients. Cytology was evaluable in 39 (88%) cases. ERCP was done in 40 (55%) patients. Pathology revealed non-neoplastic CLP in 25 (35%) and neoplastic lesions in 47 (65%) specimens. Mucinous lesions accounted for 25%. Malignant or potentially malignant CLP were found in 37 (51%) patients. Sensitivity, specificity and diagnostic accuracy of preoperative diagnosis for distinguishing between inflammatory and neoplastic, and benign and malignant was 100%, 46%, 85% and 61%, 61%, 44%, respectively.
Conclusion:
Correct and accurate preoperative assessment of CLP remains challenging. Despite the wide range of diagnostic modalities, the definitive preoperative identification of malignant or high-risk CLP is inaccurate. Because of this, a significant portion of the patients undergo pancreatic resection for benign or inflammatory lesions that are not potentially life-threatening. Possible serious complications after pancreatic surgery are the main reason for precise selection of patients with cystic affections recommended for surgery.
Key words:
cystic lesion – tumour – pancreas
Zdroje
1. Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802–7.
2. Zhang XM, Mitchell DG, Dohke M, Holland GA, Parker L. Pancreatic cysts: depiction on single-shot fast spin-echo MR images. Radiology 2002;223:547–53.
3. Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, et al. Komorowski RA,Wilson SD, Pitt HA. Cystic pancreatic neoplasms: observe or operate. Ann Surg 2004;239:651–7;
4. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, et al. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17–32.
5. Kim CB, Ahmed S, Hsueh EC. Current surgical management of pancreatic cancer. J Gastrointest Oncol 2011;2:126–35.
6. Procacci C, Biasiutti C, Carbognin G, Accordini S, Bicego E, Guarise A, et al. Characterization of cystic tumors of the pancreas: CT accuracy. J Comput Assist Tomogr 1999;23:906–12.
7. Oh HC, Kim MH, Hwang CY, Lee TY, Lee SS, et al. Cystic lesions of the pancreas: challenging issues in clinical practice. Am J Gastroenterol 2008;103:229–39; quiz 228, 240. Epub 2007 Dec 11. Review.
8. Minami M, Itai Y, Ohtomo K, Yoshida H, Yoshikawa K, et al. Cystic neoplasms of the pancreas: comparison of MR imaging with CT. Radiology 1989;171:53–6.
9. Koito K, Namieno T, Ichimura T, Yama N, Hareyama M, et al. Mucin-producing pancreatic tumors: comparison of MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Radiology 1998;208:231–7.
10. Yamao K, Nakamura T, Suzuki T, Sawaki A, Hara K, et al. Endoscopic diagnosis and staging of mucinous cystic neoplasms and intraductal papillary-mucinous tumors. J Hepatobiliary Pancreat Surg 2003;10:142–6.
11. Morris-Stiff G, Lentz G, Chalikonda S, Johnson M, Biscotti C, et al. Pancreatic cyst aspiration analysis for cystic neoplasms: mucin or carcinoembryonic antigen—which is better? Surgery 2010;148:638–44.
12. Sawhney MS, Devarajan S, O’Farrel P, Cury MS, Kundu R, et al. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc 2009;69:1106–10.
13. Farrell JJ, Fernández-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology 2013;144:1303–15.
14. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, et al. . Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138:427–3.
15. Warshaw AL, Rutledge PL. Cystic tumors mistaken for pancreatic pseudocysts. Ann Surg 1987;205:393–8.
16. Habashi S, Draganov PV. Pancreatic pseudocyst. World J Gastroenterol 2009;15:38–47. Review. PubMed PMID: 19115466.
17. Hutchins GF, Draganov PV. Cystic neoplasms of the pancreas: a diagnostic challenge. World J Gastroenterol 2009;15:48–54.
18. Zhu H, Qin L, Zhong M, Gordon R, Raoufi M, et al. Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms. Am J Surg Pathol 2012;36:305–10.
19. Khalpey Z, Rajab TK, Ashley SW. Serous cystadenoma causing the double duct sign. J Gastrointest Surg 2012;16:1282–3.
20. Thompson LD, Becker RC, Przygodzki RM, Adair CF, Heffess CS. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. Am J Surg Pathol 1999;23:1–16.
21. Azar C, Van de Stadt J, Rickaert F, DeviŹre M, Baize M, et al. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39:457–64.
22. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126:1330–6.
23. de Jong K, Bruno MJ, Fockens P. Epidemiology, diagnosis, and management of cystic lesions of the pancreas. Gastroenterol Res Pract 2012;2012: 1-8.
24. de Jong K, Poley JW, van Hooft JE, Visser M, Bruno MJ, et al. Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provils inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy 2011;43:585–90.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2013 Číslo 12
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Positive sentinel node in breast cancer – when and why also opt for axillary dissection?
- Epithelial cyst in an intrapancreatic accessory spleen – a case report
- Minimally invasive video-assisted parathyroidectomy (MIVAP) using primary hyperparathyroidism therapy (pHPT)
- Duplication of the gallbladder and cystic duct as a rare finding during cholecystectomy – a case report